COMPOUNDS WITH MEDICINAL EFFECTS DUE TO INTERACTION WITH THE GLUCOCORTICOID RECEPTOR

The invention provides for compounds having the structure according to the formula I wherein: X is a carbon or nitrogen atom; Ar is phenyl or heteroaromatic ring; R1 is hydrogen, halogen, CN or (1C-4C)alkyl; R2 is hydrogen, halogen or optionally fluorinated (1C-3C)alkoxy; R3 and R5 are independently...

Full description

Saved in:
Bibliographic Details
Main Authors GROVE, SIMON JAMES ANTHONY, OHLMEYER, MICHAEL, MORPHY, JOHN, RICHARD, LITTLEWOOD, PETER THOMAS ALBERT, SHERBORNE, BRAD, KICZUN, MICHAEL JOHN, KINGSBURY, CELIA, HO, KOC-KAN, KULTGEN, STEVEN G, HAMILTON, NIALL MORTON, BROWN, ANGUS RICHARD
Format Patent
LanguageEnglish
French
German
Published 10.09.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides for compounds having the structure according to the formula I wherein: X is a carbon or nitrogen atom; Ar is phenyl or heteroaromatic ring; R1 is hydrogen, halogen, CN or (1C-4C)alkyl; R2 is hydrogen, halogen or optionally fluorinated (1C-3C)alkoxy; R3 and R5 are independently hydrogen, optionally halogenated (1C-4C)alkyl, optionally halogenated (1C-4C)alkoxy, optionally halogenated aryl(1C-4C)alkoxy, optionally halogenated (1C-4C)alkenyl or hydroxylmethyl; R4 is hydrogen, halogen, optionally halogenated (1C-4C)alkoxy or optionally halogenated aryl(1C-4C)alkoxy; R6 is hydrogen, benzyl, optionally substituted with one or more halogens or (1C-4C)alkyl, or R6 is optionally halogenated (1C-4C)alkyl; each R7 independently is hydrogen, halogen, optionally halogenated (1C-4C)alkyl or optionally halogenated (1C-4C)alkoxy and pharmaceutically suitable acid addition salts thereof for use as glucocorticoid receptor modulators, in particular for treatment of central nervous system disorders.
Bibliography:Application Number: EP20060841409